CDR3 Therapeutics

CDR3 Therapeutics

Pre-clinical
Cambridge, United StatesFounded 2019cdr3therapeutics.com

In the fight against leukemia and lymphoma, T cells are a powerful tool. But, while modifying a human immune system through gene therapy to fight viruses and cancers is a hopeful direction, it hasn’t yet become a reality for most diseases. That’s because current technologies have short-lived effects. Which is why we developed CDR3’s unique, […]

Founded
2019
Focus
Cell & Gene Therapy

About

In the fight against leukemia and lymphoma, T cells are a powerful tool. But, while modifying a human immune system through gene therapy to fight viruses and cancers is a hopeful direction, it hasn’t yet become a reality for most diseases. That’s because current technologies have short-lived effects. Which is why we developed CDR3’s unique, […]

Funding History

4

Total raised: $58M

Series A$20MMorningside VenturesSep 15, 2022
Series A$25MUndisclosedMar 15, 2022
Seed$5MUndisclosedMar 15, 2021
Seed$8MUndisclosedMay 15, 2020

Company Info

TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile